GSK enjoys India success

Over the last few years, German engineering giant Siemens, Swiss major ABB, drugmaker GlaxoSmithKline and several others have bought larger stakes in their Indian arms.

GlaxoSmithKline (GSK) and Singapore's Institute of Chemical and Engineering Sciences (ICES) signed a five-year deal to develop evidence-based formulations (EBFs) for emerging markets such as China, Brazil, India and Russia. "EBFs are an important ...

Lot of money waiting to be deployed if FDI limit in the sector is raised to 49%, says MD Sunil Sanghai Malvika Joshi HSBC India MD Sunil Sanghai says the reason for the surge is confidence in India's long-term growth and consumption prospects.

MUMBAI: The outcome on an appeal filed by Serdia Pharmaceutical, the Indian arm of French pharmaceutical major Servier, before the is crucial for companies battling transfer pricing issues arising out of the cost of importing raw materials. Transfer ...

Attero and CARE joined hands with Glaxo SmithKline Consumer Health Care Ltd., Indigo Airlines and Quest Diagnostics for organizing an e-waste collection drive at their offices. CARE is an NGO that has been working to end poverty, social injustice ...

Asia Asian indices traded positively with most equity markets experiencing gains during the Asian session. The ASX 200 is in the green supported by the widespread bid-tone and increases in commodity prices. The Nikkei 225 outperformed, closing at ...

By | Reuters 17 minutes ago Email 0 Recommend 0 Tweet 0 Share 0 Related Content A scientist works in GlaxoSmithKline's plant in Singapore December 16, 2005. REUTERS/Luis … By Ben Hirschler LONDON (Reuters) - Thirty years ago, when the world ...

Mumbai: Indian shares took a breather on Monday and closed marginally in red on profit booking after hitting fresh 2.5 year highs. Pharma companies dragged key equity benchmarks lower while major auto stocks ended in green. The Sensex closed at ...

Top Stories S&P says downgrade risk exists, leaves rating unchanged The global rating agency Standard & Poor's (S&P) affirmed BBB- rating for India with a negative outlook. The government in it's meeting with the agency on April 25 this year ...